E-DRUG: Bioavailability studies for all generics?

e-drug
1

E-DRUG: Bioavailability studies for all generics? (cont)
------------------------------------------------------

Dear Dr Bannenberg,

This is quite an important issue which I think should be discussed within
the whole group. I sit on the advisory committee on generic and essential
drugs to be Colombian Ministry of Health, and the argument of
bio-availability testing for generics is one -the transnational
pharmaceutical industries specially- are insisting for quite strongly here
as well. Needless to say, we do not do it here.

I would be curious of what your findings are. Sincerely,

Rodolfo Dennis
Head, Clinical Epidemiology & Biostats
School of Medicine, Universidad Javeriana
Bogota, Colombia
Email: rdennis@javercol.javeriana.edu.co

--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.